Multidrug resistant acinetobacter baumannii in ventilator associated pneumonia: Prevalence and predictors of mortality Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014
Factors associated with mortality in ventilator associated pneumonia of multidrug resistant acinetobacter baumannii Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013
Effect of acenitobacter baumanii positive pneumonia on morbidity and mortality of patients Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013
Impact of candida spp. colonization of respiratory tract in patients with intensive care unit-acquired pneumonia Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013
Assessment of severity of intensive care unit-acquired pneumonia and association with aetiology Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013
LATE-BREAKING ABSTRACT: Nebulized versus intravenous amikacin in ventilator-associated pneumonia Caused by pseudomonas aeruginosa Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism Year: 2016
Carbapenemase producing Klebsiella pneumoniae (KPC+) colonization/infection in a respiratory intensive care unit: Prevalence, length of stay(LOS) and mortality Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
Methicillin-resistant staphylococcus aureus: The most prevalent cause of ventilator associated pneumonia in Tehran hospitals Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014
Community-acquired pneumonia with severe sepsis: Etiology and prognosis Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013
Severe community-acquired pneumonia in alcoholic patients hospitalized in intensive care unit Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016
Efficacy of ceftobiprole in intensive care unit (ICU) patients with hospital-acquired pneumonia (HAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014
Microbiological vs non-microbiological confirmed nnventilator ICU-acquired pneumonia Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016
Hypercapnia as a marker of ICU admission and prolonged hospitalization in patients with community-acquired pneumonia Source: International Congress 2015 – Acute critical care: news from the ICU Year: 2015
Relation between bacteremia and septic shock in patients with pneumococcal community-acquired pneumonia Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013
Nursing and healthcare-associated pneumonia requiring hospital admission: Microbiology and clinical outcomes Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
Effectiveness of immune stimulatory therapy in patient with severe community-acquired pneumonia (CAP) Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014
Ventilator-associated pneumonia (VAP) pathogenic microorganisms eradication and persistence during antimicrobial therapy Source: Annual Congress 2013 –Recent developments in pneumonia Year: 2013
Clinical and laboratory predictors of survival in patients with severe community-acquired pneumonia (CAP) Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014
Multidrug resistant acinetobacter baumanii pneumonia: Mortality analysis and comparison of intravenous versus aerosolized therapy Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
ICU-acquired pneumonia and PaO2/FIO2 value accuracy: A new paradigm? Source: International Congress 2015 – Acute critical care: news from the ICU Year: 2015